These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28700101)

  • 1. Dynamic Equilibrium of the Aurora A Kinase Activation Loop Revealed by Single-Molecule Spectroscopy.
    Gilburt JAH; Sarkar H; Sheldrake P; Blagg J; Ying L; Dodson CA
    Angew Chem Int Ed Engl; 2017 Sep; 56(38):11409-11414. PubMed ID: 28700101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation, Mg-ADP, and Inhibitors Differentially Shape the Conformational Dynamics of the A-Loop of Aurora-A.
    Musavizadeh Z; Grottesi A; Guarguaglini G; Paiardini A
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states.
    Lake EW; Muretta JM; Thompson AR; Rasmussen DM; Majumdar A; Faber EB; Ruff EF; Thomas DD; Levinson NM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11894-E11903. PubMed ID: 30518564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a Selective Aurora A Kinase Inhibitor by Virtual Screening.
    Kilchmann F; Marcaida MJ; Kotak S; Schick T; Boss SD; Awale M; Gönczy P; Reymond JL
    J Med Chem; 2016 Aug; 59(15):7188-211. PubMed ID: 27391133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Discovery and Bioactivity Evaluation of Novel Aurora-A Kinase Inhibitors as Anticancer Agents via Docking-Based Comparative Intermolecular Contacts Analysis (dbCICA).
    Hijjawi MS; Abutayeh RF; Taha MO
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33353031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain.
    Burgess SG; Oleksy A; Cavazza T; Richards MW; Vernos I; Matthews D; Bayliss R
    Open Biol; 2016 Jul; 6(7):. PubMed ID: 27411893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand discrimination between active and inactive activation loop conformations of Aurora-A kinase is unmodified by phosphorylation.
    Gilburt JAH; Girvan P; Blagg J; Ying L; Dodson CA
    Chem Sci; 2019 Apr; 10(14):4069-4076. PubMed ID: 31015948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of human protein kinase Aurora A linked to drug selectivity.
    Pitsawong W; Buosi V; Otten R; Agafonov RV; Zorba A; Kern N; Kutter S; Kern G; Pádua RA; Meniche X; Kern D
    Elife; 2018 Jun; 7():. PubMed ID: 29901437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computationally-guided optimization of small-molecule inhibitors of the Aurora A kinase-TPX2 protein-protein interaction.
    Cole DJ; Janecek M; Stokes JE; Rossmann M; Faver JC; McKenzie GJ; Venkitaraman AR; Hyvönen M; Spring DR; Huggins DJ; Jorgensen WL
    Chem Commun (Camb); 2017 Aug; 53(67):9372-9375. PubMed ID: 28787041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric Targeting of Aurora A Kinase Using Small Molecules: A Step Forward Towards Next Generation Medicines?
    Panicker RC; Coyne AG; Srinivasan R
    Curr Med Chem; 2019; 26(13):2234-2242. PubMed ID: 28748768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based drug design: Synthesis and biological evaluation of quinazolin-4-amine derivatives as selective Aurora A kinase inhibitors.
    Long L; Wang YH; Zhuo JX; Tu ZC; Wu R; Yan M; Liu Q; Lu G
    Eur J Med Chem; 2018 Sep; 157():1361-1375. PubMed ID: 30196060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition.
    Ke YY; Chang CP; Lin WH; Tsai CH; Chiu IC; Wang WP; Wang PC; Chen PY; Lin WH; Chang CF; Kuo PC; Song JS; Shih C; Hsieh HP; Chi YH
    Eur J Med Chem; 2018 May; 151():533-545. PubMed ID: 29656197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics and free energy studies on Aurora kinase A and its mutant bound with MLN8054: insight into molecular mechanism of subtype selectivity.
    Yang Y; Shen Y; Li S; Jin N; Liu H; Yao X
    Mol Biosyst; 2012 Nov; 8(11):3049-60. PubMed ID: 22990663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Click approach to the discovery of 1,2,3-triazolylsalicylamides as potent Aurora kinase inhibitors.
    Song D; Park Y; Yoon J; Aman W; Hah JM; Ryu JS
    Bioorg Med Chem; 2014 Sep; 22(17):4855-66. PubMed ID: 25042560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC Oncoproteins.
    Chi YH; Yeh TK; Ke YY; Lin WH; Tsai CH; Wang WP; Chen YT; Su YC; Wang PC; Chen YF; Wu ZW; Yeh JY; Hung MC; Wu MH; Wang JY; Chen CP; Song JS; Shih C; Chen CT; Chang CP
    J Med Chem; 2021 Jun; 64(11):7312-7330. PubMed ID: 34009981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of Coenzyme A analogues as Aurora kinase A inhibitors: An exploration of the roles of the pyrophosphate and pantetheine moieties.
    Bellany F; Tsuchiya Y; Tran TM; Chan AWE; Allan H; Gout I; Tabor AB
    Bioorg Med Chem; 2020 Nov; 28(22):115740. PubMed ID: 33007553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Aurora A-TPX2 Interaction Inhibitors Have
    Stockwell SR; Scott DE; Fischer G; Guarino E; Rooney TPC; Feng TS; Moschetti T; Srinivasan R; Alza E; Asteian A; Dagostin C; Alcaide A; Rocaboy M; Blaszczyk B; Higueruelo A; Wang X; Rossmann M; Perrior TR; Blundell TL; Spring DR; McKenzie G; Abell C; Skidmore J; Venkitaraman AR; Hyvönen M
    J Med Chem; 2024 Sep; 67(17):15521-15536. PubMed ID: 39190548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Biology Insight for the Design of Sub-type Selective Aurora Kinase Inhibitors.
    Sarvagalla S; Coumar MS
    Curr Cancer Drug Targets; 2015; 15(5):375-93. PubMed ID: 25895501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design.
    Chang CF; Lin WH; Ke YY; Lin YS; Wang WC; Chen CH; Kuo PC; Hsu JTA; Uang BJ; Hsieh HP
    Eur J Med Chem; 2016 Nov; 124():186-199. PubMed ID: 27573544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dual aurora and lim kinase inhibitor reduces glioblastoma proliferation and invasion.
    Rybin MJ; Laverde-Paz MJ; Suter RK; Affer M; Ayad NG; Feng Y; Zeier Z
    Bioorg Med Chem Lett; 2022 Apr; 61():128614. PubMed ID: 35151865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.